TNF-α, IL-6, IL-1β, C-reactive protein, and NF-κB are highly probable biomarkers of GDM and may eventually be utilized for GDM screening in early and late pregnancy (Khambule & George, 2019). This evidence concerns the gene NFKB1 and gestational diabetes.